Mumbai: After setting up an Asian pharmaceutical development centre in India to enhance its market presence with region specific drugs last year, French drug maker Sanofi-Aventis is now looking at expanding its reach into the Indian rural market by acquiring domestic brands in non-speciality segments.
The product segments that the company is looking under this plan would include cough and cold, anti-infection, and other minor ailments. “We are exploring growth opportunities in the Indian rural markets by acquiring suitable brands and businesses here ,” said Shailesh Ayyangar, managing director, Aventis Pharma Ltd, the Indian arm of Sanofi.
Already a key player in the domestic anti-diabetes market with a wide range of products in oral therapy as well as insulins, Sanofi announced the launch of its latest insulin pen SoloStar on Tuesday.
- C.H. Unnikrishnan
Subex in red, posts Rs68 crore net loss
Bangalore: Telecom software maker Subex Ltd slipped into red for the year to March as client specific issues and underestimation of business transitioning costs from acquired entity Syndesis Ltd impacted revenue flows during the year.
Subex posted a net loss of Rs68.10 crore on revenues of Rs485 crore, that fell short of its own forecast for the year-to March, as against a profit of Rs67.56 crore on revenue of Rs340 crore in the year-ago period.
Revenue from products stood at Rs361.5 crore accounting for three-fourth of the revenue for the year.
Subex shares closed 11% lower at Rs175.9 on the Bombay Stock Exchange.
- Vishwanath Kulkarni
Network18 Q4 net profit up 161% to Rs41 crore
New Delhi: Network18 Media and Investments Ltd, the holding company of the Network18 group, posted a net profit of Rs41 crore for the quarter ended 31 March.
The firm said a surge in revenues and profitability at all business units helped it post a 161% growth in net profit year-on-year. News operations, Web properties and the films business performed well.
For the 2007-08 financial year, the firm posted a net profit of Rs21.1 crore, compared with a net loss of Rs9.4 crore the previous fiscal.
- Sruthijith K.K.